WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2016086153) USE OF HSP90 INHIBITORS FOR THE TREATMENT OF HIV INFECTIONS AND AIDS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2016/086153    International Application No.:    PCT/US2015/062715
Publication Date: 02.06.2016 International Filing Date: 25.11.2015
IPC:
A61K 31/403 (2006.01), A61K 31/404 (2006.01), A61K 31/416 (2006.01), A61K 31/4178 (2006.01), A61K 31/42 (2006.01), A61K 31/4406 (2006.01), A61K 31/4468 (2006.01), A61K 31/5377 (2006.01), A61K 31/55 (2006.01), A61K 45/06 (2006.01), A61P 31/18 (2006.01)
Applicants: ESANEX, INC. [US/US]; 115 W. Washington Street Suite 1680-S Indianapolis, IN 46204 (US).
DUKE UNIVERSITY [US/US]; 2812 Erwin Road, Suite 306 Box 90083 Durham, NC 27705 (US).
OHIO STATE INNOVATION FOUNDATION [US/US]; 1524 North High Street Columbus, OH 43201 (US)
Inventors: ORLEMANS, Everardus, O. M.; (US).
HAYNES, Barton, F.; (US).
FERRARI, Guido; (US).
HAYSTEAD, Timothy; (US).
KWIEK, Jesse, John; (US)
Agent: SARUSSI, Steven, J.; (US)
Priority Data:
62/085,062 26.11.2014 US
Title (EN) USE OF HSP90 INHIBITORS FOR THE TREATMENT OF HIV INFECTIONS AND AIDS
(FR) UTILISATION DE DÉRIVÉS DE TÉTRAHYDROINDAZOLYLBENZAMIDE ET TÉTRAHYDROINDOLYLBENZAMIDE POUR LE TRAITEMENT DU VIRUS DE L'IMMUNODÉFICIENCE HUMAINE (VIH) ET DU SYNDROME D'IMMUNODÉFICIENCE ACQUISE (SIDA)
Abstract: front page image
(EN)Provided are methods of treating or inhibiting Human Immunodeficiency Virus (HIV) infection, or treating or inhibiting Acquired Human Immunodeficiency Syndrome (AIDS) in a subject in need thereof, comprising administering an Hsp90 inhibitor in a therapeutically effective amount.
(FR)L'invention concerne des méthodes de traitement ou d'inhibition d'une infection par le virus de l'immunodéficience humaine (VIH), ou de traitement ou d'inhibition du syndrome d'immunodéficience humaine acquise (SIDA) chez un sujet en ayant besoin, comprenant l'administration d'un inhibiteur de Hsp90 dans une quantité thérapeutiquement efficace.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)